Glucuronidation: an important mechanism for detoxification of benzo[a]pyrene metabolites in aerodigestive tract tissues.

UDP-glucuronosyltransferases (UGTs) have been implicated as important detoxifying enzymes for several major tobacco carcinogens. Because the aerodigestive tract is a primary target for exposure to tobacco smoke carcinogens, the major goal of the present study was to determine whether aerodigestive tract tissues exhibit glucuronidating activity against metabolites of benzo[a]pyrene (BaP) and to explore the pattern of expression of UGT genes in a series of aerodigestive tract tissue specimens. Glucuronidation of the phenolic BaP metabolites 3-, 7-, and 9-hydroxy-BaP was observed in all upper aerodigestive tract tissue microsome specimens tested, as determined by high-pressure liquid chromatography analysis. Glucuronidating activity toward the procarcinogenic BaP metabolite trans-BaP-7,8-dihydrodiol(+/-) was also detected in aerodigestive tract tissues. By semiquantitative duplex reverse transcription-polymerase chain reaction analysis, UGT1A7 and UGT1A10 were shown to be well expressed in all aerodigestive tract tissues examined, including tongue, tonsil, floor of mouth, larynx, and esophagus. UGT1A8 and UGT1A6 were expressed primarily in larynx; no expression was observed for UGTs 1A1, 1A3, 1A4, 1A5, 1A9. Of the family 2B UGTs, only UGT2B4 and UGT2B17 exhibited significant levels of expression in aerodigestive tract tissues. Of the aerodigestive tract-expressing UGTs, only UGTs 1A7, 1A8, and 1A10 exhibited glucuronidating activity against 7-hydroxy-BaP, with UGT1A10 exhibiting the highest affinity as determined by kinetic analysis (K(m) = 49 microM). No UGT expression or glucuronidating activity was observed for any of the lung specimens analyzed in this study. These results suggest that several family 1 UGTs may potentially play an important role in BaP detoxification in the aerodigestive tract.

[1]  N. Nemoto,et al.  Glucuronidation of benzo[a]pyrene in hamster embryo cells. , 1978, Chemico-biological interactions.

[2]  C. Legraverend,et al.  Mutagenesis of certain benzo(a)pyrene phenols in vitro following further metabolism by mouse liver. , 1979, Biochemical pharmacology.

[3]  B. Burchell,et al.  Purification and properties of rat kidney UDP-glucuronosyltransferase. , 1987, Biochemical pharmacology.

[4]  B. Burchell,et al.  UDP-glucuronosyltransferases: a family of detoxifying enzymes. , 1990, Trends in pharmacological sciences.

[5]  P. G. Wells,et al.  In vitro and in vivo biotransformation and covalent binding of benzo(a)pyrene in Gunn and RHA rats with a genetic deficiency in bilirubin uridine diphosphate-glucuronosyltransferase. , 1992, The Journal of pharmacology and experimental therapeutics.

[6]  J. Miners,et al.  cDNA cloning and expression of two new members of the human liver UDP-glucuronosyltransferase 2B subfamily. , 1993, Biochemical and biophysical research communications.

[7]  B. Burchell,et al.  Substrate specificities of two stably expressed human liver UDP-glucuronosyltransferases of the UGT1 gene family. , 1993, Drug metabolism and disposition: the biological fate of chemicals.

[8]  J. Miners,et al.  The glucuronidation of hydroxylated metabolites of benzo[a]pyrene and 2-acetylaminofluorene by cDNA-expressed human UDP-glucuronosyltransferases. , 1993, Carcinogenesis.

[9]  P. G. Wells,et al.  Modulation of benzo[a]pyrene bioactivation by glucuronidation in lymphocytes and hepatic microsomes from rats with a hereditary deficiency in bilirubin UDP-glucuronosyltransferase. , 1994, Toxicology and applied pharmacology.

[10]  J. Ritter,et al.  Gene structure at the human UGT1 locus creates diversity in isozyme structure, substrate specificity, and regulation. , 1995, Progress in nucleic acid research and molecular biology.

[11]  P. G. Wells,et al.  Potential genoprotective role for UDP-glucuronosyltransferases in chemical carcinogenesis: initiation of micronuclei by benzo(a)pyrene and benzo(e)pyrene in UDP-glucuronosyltransferase-deficient cultured rat skin fibroblasts. , 1995, Cancer research.

[12]  D. Hum,et al.  Chromosomal localization, structure, and regulation of the UGT2B17 gene, encoding a C19 steroid metabolizing enzyme. , 1997, DNA and cell biology.

[13]  R. Metz,et al.  Identification of a Rat Oltipraz-inducible UDP-glucuronosyltransferase (UGT1A7) with Activity Towards Benzo(a)pyrene-7,8-dihydrodiol* , 1997, The Journal of Biological Chemistry.

[14]  K. Bock,et al.  Drug-metabolizing enzymes in pharyngeal mucosa and in oropharyngeal cancer tissue. , 1997, Biochemical pharmacology.

[15]  S. Hecht,et al.  Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in black and white smokers. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[16]  M. Green,et al.  Isolation and characterization of UGT2B15(Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene. , 1997, Pharmacogenetics.

[17]  D. Hum,et al.  Isolation and characterization of a human orphan UDP-glucuronosyltransferase, UGT2B11. , 1998, Biochemical and biophysical research communications.

[18]  M. Manns,et al.  Expression of the UDP-glucuronosyltransferase 1A Locus in Human Colon , 1998, The Journal of Biological Chemistry.

[19]  P. Mackenzie,et al.  Characterization of two UDP glucuronosyltransferases that are predominantly expressed in human colon. , 1998, Biochemical and biophysical research communications.

[20]  T. Tephly,et al.  Cloning and expression of human UDP-glucuronosyltransferase (UGT) 1A8. , 1998, Archives of biochemistry and biophysics.

[21]  F. Guéraud,et al.  Glucuronidation: a dual control. , 1998, General pharmacology.

[22]  C. Guillemette,et al.  Characterization and regulation of UDP-glucuronosyltransferases in steroid target tissues 1 1 Proceedings of the 13th International Symposium of the Journal of Steroid Biochemistry & Molecular Biology “Recent Advances in Steroid Biochemistry & Molecular Biology” Monaco, 25–28 May 1997. , 1998, The Journal of Steroid Biochemistry and Molecular Biology.

[23]  M. Manns,et al.  Polymorphic expression of the UDP-glucuronosyltransferase UGT1A gene locus in human gastric epithelium. , 1998, Molecular pharmacology.

[24]  T. Tephly,et al.  Studies on the substrate specificity of human intestinal UDP- lucuronosyltransferases 1A8 and 1A10. , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[25]  M. Manns,et al.  Regulation and function of family 1 and family 2 UDP-glucuronosyltransferase genes (UGT1A, UGT2B) in human oesophagus. , 1999, The Biochemical journal.

[26]  D. Hum,et al.  Characterization and substrate specificity of UGT2B4 (E458): a UDP-glucuronosyltransferase encoded by a polymorphic gene. , 1999, Pharmacogenetics.

[27]  M. Manns,et al.  Regulation and function of family 1 and family 2 UDP-glucuronosyltransferase genes ( UGT 1 A , UGT 2 B ) in human oesophagus , 1999 .

[28]  T. Tephly,et al.  Expression of UDP-glucuronosyltransferases (UGTs) 2B7 and 1A6 in the human brain and identification of 5-hydroxytryptamine as a substrate. , 1999, Archives of Biochemistry and Biophysics.

[29]  A. Dannenberg,et al.  Glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by rat UDP-glucuronosyltransferase 2B1. , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[30]  C. Guillemette,et al.  Characterization of UDP-glucuronosyltransferases active on steroid hormones , 1999, The Journal of Steroid Biochemistry and Molecular Biology.

[31]  S. Murphy,et al.  O-Glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1- (3-pyridyl)-1-butanol (NNAL) by human UDP-glucuronosyltransferases 2B7 and 1A9. , 2000, Drug metabolism and disposition: the biological fate of chemicals.

[32]  D. Hum,et al.  Isolation and characterization of the human UGT2B7 gene. , 2000, Biochemical and biophysical research communications.

[33]  C. Guillemette,et al.  Structural heterogeneity at the UDP-glucuronosyltransferase 1 locus: functional consequences of three novel missense mutations in the human UGT1A7 gene. , 2000, Pharmacogenetics.

[34]  R. Tukey,et al.  Human UDP-glucuronosyltransferases: metabolism, expression, and disease. , 2000, Annual review of pharmacology and toxicology.

[35]  M. Manns,et al.  Polymorphic Gene Regulation and Interindividual Variation of UDP-glucuronosyltransferase Activity in Human Small Intestine* , 2000, The Journal of Biological Chemistry.

[36]  J. Shay,et al.  Effects of chemopreventive and antitelomerase agents on the spontaneous immortalization of breast epithelial cells. , 2001, Journal of the National Cancer Institute.

[37]  C. Guillemette,et al.  Tobacco carcinogen-detoxifying enzyme UGT1A7 and its association with orolaryngeal cancer risk. , 2001, Journal of the National Cancer Institute.

[38]  C. Guillemette,et al.  by Human Tissue Microsomes and Overexpressed UDP-glucuronosyltransferase Enzymes 1 , 2002 .